ArticleJAC-antimicrobial resistance2025
Patient conversations that matter: assessing the role of TARGET TYI leaflets for respiratory care in England's community pharmacies.
Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The TARGET Treating Your Infection (TYI-RTI) leaflets are designed to support healthcare professionals in delivering tailored conversations with patients about respiratory tract infection (RTI) symptoms. This study evaluated their use across community pharmacies in England through the Pharmacy Quality Scheme (PQS). Methods: In 2022-23 and 2023-24, the PQS incentivized community pharmacies to use TYI-RTI leaflets for patients presenting with upper RTIs during a 4 week period each year. Results: Across the 2 years, 225 615 patients were reviewed using TYI-RTI leaflets. A total of 7525 pharmacies participated in at least 1 year, with 7407 taking part in both. The proportion of patients requiring escalation to the pharmacist fell from 23% (26 678) in 2022-23 to 15% (16 417) in 2023-24. Approximately one-third of patients were managed entirely by the wider pharmacy team. Signposting to another healthcare provider also declined, from 12% (13 248) to 7% (8250; Conclusions: Community pharmacies successfully used TYI-RTI leaflets to support patient self-care, reassurance and safety-netting, reducing the need for escalation. The study highlights the role of TYI-RTI in optimizing pharmacy-led RTI management and reducing pressure on wider healthcare services. Incentivization was an effective tool for improving AMS in community pharmacy at pace.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.